Ilex Medical

Ilex Medical EBIT per Employee

The EBIT per Employee of Ilex Medical (ILX.TA) as of Oct 24, 2026 is 258,584.31 ILS. In the previous year, EBIT per Employee was 323,125.49 ILS — a change of -19.97% (lower).

EBIT per Employee

258,584.31ILS

YoY

-19.97%

Last updated:

EBIT per Employee of Ilex Medical is 2024 258,584.31 ILS. EBIT per Employee of Ilex Medical was 2023 323,125.49 ILS. It decreases by -19.97% lower compared to the previous year.

The Ilex Medical EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2017
209,345.10 ILS
Jan 1, 2018
297,301.96 ILS
Jan 1, 2019
324,976.47 ILS
Jan 1, 2020
589,909.80 ILS
Jan 1, 2021
1.01 M ILS
Jan 1, 2022
554,780.39 ILS
Jan 1, 2023
323,125.49 ILS
Jan 1, 2024
258,584.31 ILS
The Ilex Medical EBIT per Employee history
YEAREBIT per EmployeeYoY
258,584.31ILS-19.97%
323,125.49ILS-41.76%
554,780.39ILS-44.98%
1.01 MILS+70.94%
589,909.80ILS+81.52%
324,976.47ILS+9.31%
297,301.96ILS+42.02%
209,345.10ILS+6.85%
195,925.49ILS-7.89%
212,698.04ILS+28.65%
165,333.33ILS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ilex Medical Stock analysis

What does Ilex Medical do? Ilex Medical Ltd supplies in vitro diagnostic equipment and laboratory management software, targeting healthcare providers and laboratories. The company offers nucleic acid testing (NAT) blood screening solutions, cancer screening products, retro virus load monitoring, TB and STD testing systems, and blood sugar monitoring devices. Its subsidiaries include Ilex South Africa, Orsyx-LIS, Ilex BioTech Ltd, and Medtechnica Ltd, which support its diagnostic equipment and software distribution. Healthcare facilities and diagnostic laboratories purchase these products for clinical testing and patient management. Ilex Medical Ltd's revenue streams come from selling diagnostic equipment, reagent systems, and laboratory information systems (LIS) to healthcare institutions. The firm's NAT blood screening solutions and infectious disease testing systems are key products for blood banks and public health labs. Subsidiaries like Orsyx-LIS provide specialized laboratory management software, enhancing the company's offerings in the diagnostic software segment. Hospitals and clinics rely on these solutions for efficient diagnostic workflows. The company serves segments including hospitals, blood banks, public health laboratories, and clinics focused on infectious disease management. Products such as cancer screening tools and retro virus load systems are sold to specialized medical facilities. Ilex South Africa and Medtechnica Ltd extend the company's reach in regional markets, supporting localized sales and service. Diagnostic software from Orsyx-LIS is integrated into laboratory workflows for improved data management. Ilex Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ilex Medical stock

EBIT per Employee of Ilex Medical is 258,584.31 ILS in 2024.

EBIT per Employee of Ilex Medical changed from 323,125.49 ILS to 258,584.31 ILS, representing a -19.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Ilex Medical since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's ILS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Ilex Medical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Ilex Medical

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Ilex Medical